Cytarabine and Ureaplasma infection (expanded source)


Ureaplasma infection is found among people who take Cytarabine, especially for people who are male, 20-29 old also take medication Cisplatin, and have Acute myeloid leukaemia. This study is created by eHealthMe based on reports of 30,491 people who have side effects when taking Cytarabine from FDA, and is updated regularly.

How to use this study: bring a copy to your health teams to ensure drug risks and benefits are fully discussed and understood.

Who is eHealthMe: we are a data analysis company who specializes in health care industry. Our original studies have been referenced on 500+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and EANO. On eHealthMe, you can research drugs and monitor them (see testimonials).



On Oct, 18, 2018

30,491 people reported to have side effects when taking Cytarabine.
Among them, 6 people (0.02%) have Ureaplasma infection


Number of reports submitted per year:

Could Cytarabine cause Ureaplasma infection?

Gender of people who have Ureaplasma infection when taking Cytarabine *:

  • female: 50 %
  • male: 50 %

Age of people who have Ureaplasma infection when taking Cytarabine *:

Top conditions involved for these people *:

  1. Diffuse Large B-Cell Lymphoma Stage Ii (cancer of b cells, a type of white blood cell-stage ii): 1 person, 16.67%
  2. Chloroma (green-coloured tumour): 1 person, 16.67%
  3. Chemotherapy: 1 person, 16.67%
  4. Bone Marrow Conditioning Regimen: 1 person, 16.67%
  5. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 1 person, 16.67%

Top co-used drugs for these people *:

  1. Methylprednisolone: 3 people, 50.00%
  2. Methotrexate: 3 people, 50.00%
  3. Fludarabine Phosphate: 3 people, 50.00%
  4. Etoposide: 3 people, 50.00%
  5. Cisplatin: 3 people, 50.00%

Click here to view more results or personalize the results to your gender and age

Top other side effects for these people *:

  1. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 50.00%
  2. Arthritis Bacterial (form of joint disorder that involves inflammation of one or more joints due to bacterial infection): 3 people, 50.00%
  3. Disseminated Intravascular Coagulation (systemic activation of blood coagulation): 3 people, 50.00%
  4. Hyperammonaemic Encephalopathy (excess of ammonia in the blood, disorder or disease of the brain): 3 people, 50.00%
  5. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 33.33%

Click here to view more results or personalize the results to your gender and age

* Approximation only. Some reports may have incomplete information.

FDA reports used in this study



Do you have Ureaplasma infection while taking Cytarabine?


You are not alone:




Related studies

Cytarabine

Cytarabine has active ingredients of cytarabine. It is often used in acute myelogenous leukemia (aml) - adult. (latest outcomes from Cytarabine 30,511 users)

Ureaplasma infection

Ureaplasma infection has been reported by people with hiv infection, immunodeficiency disorders, crohn's disease, staphylococcal infection, lung transplant (latest reports from 87 Ureaplasma infection patients).


Drugs that are associated with Ureaplasma infection
Ureaplasma infection (42 drugs)
Could your condition cause Ureaplasma infection
Ureaplasma infection (35 conditions)
Cytarabine side effects
Browse all side effects of Cytarabine
a b c d e f g h i j k l m n o p q r s t u v w x y z

What would happen?

Predict new side effects and undetected conditions when you take Cytarabine and have Ureaplasma infection


Recent updates

Recent general studies
Recent personal studies

NOTE: The study is based on active ingredients and brand name. Other drugs that have the same active ingredients (e.g. generic drugs) are NOT considered.

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at http://www.fda.gov/medwatch/ or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.